• Financing

MELAG Medizintechnik Financing in the Context of the Reorganisation of the Shareholder Structure

The Company

MELAG Medizintechnik GmbH & Co. KG ("MELAG") is a in third generation family-owned medical technology company founded in 1951, headquartered in Berlin. 

The company develops and produces "made in Germany" solutions for instrument reprocessing in practices and clinics and exports, among other things, sterilisers and disinfectors to over 80 countries. With almost 500 employees, MELAG is the world market leader in its market segment.

The Transaction

In the context of the upcoming reorganisation of the shareholder structure, the objective was to cover essential financing needs of this reorganisation by the company. At the same time, the financing flexibility for the company's continued very strong growth prospects was to be maintained or even expanded. 

Against this backdrop, MELAG aimed to establish a broader external debt financing structure for the first time that could cover the various financing needs simultaneously on a long-term and flexible basis. 

On the basis of corresponding transaction dialogues with a group of selected potential financing partners, a financing solution consisting of several medium- and long-term bank loan tranches with a mix of fixed and variable interest rates as well as fixed, variable and revolving repayment profiles was ultimately implemented.

Scope of Mandate

ARGONAS advised and supported MELAG [and its majority shareholders] as exclusive corporate finance advisor on all aspects of the transaction (including the development of a strategic financial plan as well as the structuring and implementation of the financing concept).